pH responsible and fluorescent Cy5.5-PEG-g-A-HA/CDDP complex nanoparticles: synthesis, characterization, and application for targeted drug delivery.
Aldehydes
/ chemistry
Antineoplastic Agents
/ administration & dosage
Carbocyanines
/ chemistry
Cell Line, Tumor
Cisplatin
/ administration & dosage
Drug Carriers
Drug Delivery Systems
Fluorescent Dyes
/ chemistry
HeLa Cells
Hemolysis
Humans
Hyaluronic Acid
/ chemistry
Hydrogen-Ion Concentration
Imines
/ chemistry
Nanoparticles
/ chemistry
Neoplasms
/ drug therapy
Polyethylene Glycols
/ chemistry
Spectroscopy, Fourier Transform Infrared
Thermogravimetry
X-Ray Diffraction
Journal
Journal of materials science. Materials in medicine
ISSN: 1573-4838
Titre abrégé: J Mater Sci Mater Med
Pays: United States
ID NLM: 9013087
Informations de publication
Date de publication:
24 May 2019
24 May 2019
Historique:
received:
06
12
2018
accepted:
06
05
2019
entrez:
26
5
2019
pubmed:
28
5
2019
medline:
18
12
2019
Statut:
epublish
Résumé
Clinical application of cisplatin (CDDP) against various solid tumors is often limited due to its poor selectivity and severe side effect. Considering this, in our study, CDDP was incorporated in fluorescent PEG amine grafted aldehyde hyaluronic acid by imine bond and metal ion coordination bond linking and formed a complex, the complex was then self-assembled into nanoparticles in water simply. FT-IR, XRD, DLS and SEM analysis demonstrated that the nanoparticles were prepared successfully and exhibited a spherical structure with size ranged from 216.4 to 372.3 nm in diameter. CDDP releasing from the nanoparticles was in a controlled manner, and had faster release rate at lower pH, indicating the nanoparticles were responsive to tumor micro-acid environment. Since fluorescent Cy5.5 and targeting hyaluronic acid existed on the surface of the nanoparticles, CLSM images clearly showed that the nanoparticles could target and internalize into HeLa cells, and then inhibited the growth of HeLa cells. In addition, MTT, AO-EB staining, and hemolysis assay showed that the nanoparticles had good cyto-/hemo-compatibility. Hence, the nanoparticles had the potential to be used for cancer therapy and diagnosis. The further in vivo experiment will be shown in the next work. pH responsible and fluorescent Cy5.5-PEG-g-A-HA/CDDP complex nanoparticles were facilely fabricated for controlled and targeted delivery of CDDP.
Identifiants
pubmed: 31127370
doi: 10.1007/s10856-019-6260-8
pii: 10.1007/s10856-019-6260-8
doi:
Substances chimiques
Aldehydes
0
Antineoplastic Agents
0
CY5.5 cyanine dye
0
Carbocyanines
0
Drug Carriers
0
Fluorescent Dyes
0
Imines
0
Polyethylene Glycols
3WJQ0SDW1A
Hyaluronic Acid
9004-61-9
Cisplatin
Q20Q21Q62J
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
58Subventions
Organisme : Natural Science Foundation of Fujian Province
ID : 2016J01733
Organisme : Natural Science Foundation of Fujian Province
ID : 2017J01179
Organisme : National Natural Science Foundation of China
ID : 31771893
Références
Biomaterials. 2009 May;30(13):2499-506
pubmed: 19167750
Acta Biomater. 2015 May;18:68-76
pubmed: 25707922
J Biomed Mater Res A. 2008 Jun 1;85(3):787-96
pubmed: 17896762
Colloids Surf B Biointerfaces. 2016 Aug 1;144:293-302
pubmed: 27107383
Drug Discov Today. 2001 Jan 1;6(1):44-51
pubmed: 11165172
J Pharm Sci. 2008 Mar;97(3):1268-76
pubmed: 17674407
J Control Release. 2015 May 10;205:89-97
pubmed: 25529533
Int J Biol Macromol. 2018 Feb;107(Pt B):2180-2189
pubmed: 29132812
Biomater Sci. 2016 Aug 19;4(8):1212-8
pubmed: 27315174
Biomater Sci. 2015 Oct 15;3(10):1386-94
pubmed: 26301700
J Pharm Sci. 2010 Jun;99(6):2664-71
pubmed: 19960530
Mol Pharm. 2010 Feb 1;7(1):280-90
pubmed: 19994852
J Biomed Res. 2010 Jan;24(1):26-32
pubmed: 23554608
Mol Ther Nucleic Acids. 2013 Jul 30;2:e110
pubmed: 23900224
Biomaterials. 2014 Mar;35(9):3005-14
pubmed: 24388813
Colloids Surf B Biointerfaces. 2015 May 1;129:63-70
pubmed: 25829128
Biomaterials. 2009 Jul;30(20):3476-85
pubmed: 19345990
Colloids Surf B Biointerfaces. 2018 Jan 1;161:35-41
pubmed: 29040832
Biomater Sci. 2017 Mar 28;5(4):752-761
pubmed: 28256649
Macromol Biosci. 2014 Sep;14(9):1337-45
pubmed: 24933015
Biomacromolecules. 2015 Aug 10;16(8):2463-74
pubmed: 26166192
Biomacromolecules. 2016 May 9;17(5):1621-32
pubmed: 27018501
Cancers (Basel). 2011 Mar 15;3(1):1351-71
pubmed: 24212665
Colloids Surf B Biointerfaces. 2015 Dec 1;136:346-54
pubmed: 26433347
Int J Pharm. 2015 Dec 30;496(2):644-53
pubmed: 26529576
Macromol Biosci. 2012 Nov;12(11):1514-23
pubmed: 23070837
Biomed Pharmacother. 2015 Aug;74:243-51
pubmed: 26349992
Colloids Surf B Biointerfaces. 2014 Oct 1;122:350-358
pubmed: 25078298
Colloids Surf B Biointerfaces. 2018 Feb 1;162:271-278
pubmed: 29216514